Regarding the use of IL-8 level as a measurement for pancreatic cancer treatment, five studies in total all came to quite consistent results that a lower level of IL-8 indicated better survival (36–38, 44, 102). The gene discussed is CXCL8; the disease is familial pancreatic carcinoma.